AVCNX
Price
$17.65
Change
-$0.02 (-0.11%)
Updated
Dec 26 closing price
Net Assets
1.24B
VSCAX
Price
$25.84
Change
+$0.03 (+0.12%)
Updated
Dec 26 closing price
Net Assets
8.33B
Interact to see
Advertisement

AVCNX vs VSCAX

Header iconAVCNX vs VSCAX Comparison
Open Charts AVCNX vs VSCAXBanner chart's image
Avantis® U.S. Small Cap Value G
Price$17.65
Change-$0.02 (-0.11%)
VolumeN/A
Net Assets1.24B
Invesco Small Cap Value A
Price$25.84
Change+$0.03 (+0.12%)
VolumeN/A
Net Assets8.33B
AVCNX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 8.33B vs. AVCNX (1.24B). AVCNX pays higher dividends than VSCAX: AVCNX (1.52) vs VSCAX (0.31). AVCNX was incepted earlier than VSCAX: AVCNX (5 years) vs VSCAX (27 years). VSCAX (1.10) is less costly to investors than AVCNX (0.25). VSCAX is a more actively managed with annual turnover of: 52.00 vs. AVCNX (21.00). AVCNX has a lower initial minimum investment than VSCAX: AVCNX (0) vs VSCAX (1000). VSCAX annual gain was more profitable for investors over the last year : 8.71 vs. AVCNX (2.14).
AVCNXVSCAXAVCNX / VSCAX
Total Expense Ratio0.001.10-
Annual Report Gross Expense Ratio0.251.1023%
Fund Existence5 years27 years-
Gain YTD3.4589.91135%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B8.33B15%
Annual Yield % from dividends1.520.31495%
Returns for 1 year2.148.7125%
Returns for 3 years35.1349.4671%
Returns for 5 yearsN/A66.73-
Returns for 10 yearsN/A59.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAMP5.960.04
+0.68%
Camp4 Therapeutics Corp
AZN92.900.45
+0.49%
AstraZeneca PLC
QTTB3.20N/A
N/A
Q32 Bio
ESAB114.21-0.06
-0.05%
ESAB Corp
LAC4.69-0.17
-3.50%
Lithium Americas Corp